<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 4.3: Metabolic and Inflammatory Biomarkers</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE/TEAL theme for Data-Driven Decisions */
        .module-header {
            background: linear-gradient(135deg, #0f172a 0%, #1e293b 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e293b;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #B8860B;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e293b;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f8fafc;
            border: 2px solid #334155;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e293b;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e293b;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #334155;
            margin: 30px 0 15px 0;
            font-weight: 600;
        }

        /* Paragraphs & Text */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
            border: 1px solid #e2e8f0;
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e293b 0%, #334155 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
            letter-spacing: 0.5px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        /* Stats Box */
        .stats-box {
            background: linear-gradient(135deg, #1e293b 0%, #334155 100%);
            padding: 35px;
            border-radius: 16px;
            margin: 35px 0;
            color: white;
        }

        .stat-highlight {
            font-size: 24px;
            font-weight: 700;
            color: #D4A84B;
            display: block;
            margin-bottom: 5px;
        }

        /* Comparison Table */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e2e8f0;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background: #f1f5f9;
            padding: 15px;
            font-weight: 600;
            color: #1e293b;
            border-bottom: 2px solid #e2e8f0;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #e2e8f0;
            color: #475569;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: #fdfbf7;
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #1e293b;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            font-family: inherit;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f1f5f9;
            border-radius: 8px;
            color: #1e293b;
        }

        /* References Box */
        .references-box {
            background: #f8fafc;
            padding: 30px;
            border-radius: 12px;
            margin-top: 40px;
            font-size: 14px;
            color: #64748b;
            border: 1px solid #e2e8f0;
        }

        .references-box h4 {
            margin: 0 0 15px 0;
            color: #1e293b;
            font-size: 16px;
        }

        .references-box ul {
            padding-left: 20px;
            margin: 0;
        }

        .references-box li {
            margin-bottom: 8px;
        }

        /* Key Takeaways */
        .takeaways-box {
            background: #f1f5f9;
            padding: 25px 30px;
            margin: 40px 0;
            border-radius: 12px;
            border-left: 5px solid #1e293b;
        }

        .takeaways-box .box-label {
            font-weight: 700;
            color: #1e293b;
            margin-bottom: 15px;
            display: block;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            opacity: 0.8;
        }

        @media (max-width: 768px) {
            .lesson-container { padding: 20px 15px; }
            .toc-list { grid-template-columns: 1fr; }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="https://accredipro.com/wp-content/uploads/2023/05/AccrediPro-Logo-1.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 4: Data-Driven Decisions</p>
            <h1 class="lesson-title">Lesson 4.3: Metabolic and Inflammatory Biomarkers</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Expert Level</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#glycemic"><span class="section-num">1</span>Advanced Glycemic Assessment</a></li>
                <li><a href="#inflammation"><span class="section-num">2</span>The Inflammation Trinity</a></li>
                <li><a href="#cardio"><span class="section-num">3</span>Cardiovascular Risk 2.0</a></li>
                <li><a href="#uric"><span class="section-num">4</span>Uric Acid: The Smoke Detector</a></li>
                <li><a href="#interplay"><span class="section-num">5</span>The Metabolic-Inflammatory Loop</a></li>
                <li><a href="#clinical"><span class="section-num">6</span>Clinical Application Protocols</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Master the calculation and interpretation of HOMA-IR for early detection of insulin resistance.</li>
                <li>Differentiate between standard lipid panels and advanced markers like ApoB and Lp(a).</li>
                <li>Analyze the synergy between hs-CRP, Homocysteine, and Ferritin in systemic inflammation.</li>
                <li>Utilize Uric Acid as a metabolic "smoke detector" for fructose intolerance and oxidative stress.</li>
                <li>Synthesize metabolic and inflammatory data to create precision intervention strategies.</li>
            </ul>
        </div>

        <p>In Lesson 4.2, we explored the nuances of functional blood chemistry, moving beyond the "normal" range into the "optimal" range. Now, we narrow our focus to the two most critical drivers of chronic disease: <span class="highlight">metabolic dysfunction</span> and <span class="highlight">chronic systemic inflammation</span>. These are not isolated states; they are a feedback loop where one fuels the other, creating the "inflammaging" phenotype common in modern clinical practice.</p>

        <h2 id="glycemic">1. Advanced Glycemic Assessment: Beyond HbA1c</h2>
        <p>Traditional medicine relies heavily on Hemoglobin A1c (HbA1c) and Fasting Glucose. While useful, HbA1c is a three-month average that can be skewed by red blood cell turnover. To truly practice <span class="highlight">Data-Driven Decisions</span> (the "D" in our B.R.I.D.G.E. framework), we must look at the driver of glucose: <span class="highlight">Insulin</span>.</p>

        <div class="stats-box">
            <span class="stat-highlight">88% of US Adults</span>
            <p>A 2019 study published in <i>Metabolic Syndrome and Related Disorders</i> found that only 12.2% of American adults are metabolically healthy, meaning 88% show at least one biomarker of metabolic dysfunction, often years before HbA1c rises.</p>
        </div>

        <h3>The HOMA-IR Calculation</h3>
        <p>The Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) is the gold standard for identifying subclinical insulin resistance. It is calculated as: 
        <br><strong>(Fasting Insulin [ÂµIU/mL] Ã— Fasting Glucose [mg/dL]) / 405</strong>.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Marker</th>
                        <th>Conventional Range</th>
                        <th>Functional Optimal</th>
                        <th>Clinical Significance</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td>Fasting Insulin</td>
                        <td>2.6 â€“ 24.9 ÂµIU/mL</td>
                        <td>2.0 â€“ 5.0 ÂµIU/mL</td>
                        <td>Early marker of metabolic syndrome.</td>
                    </tr>
                    <tr>
                        <td>HOMA-IR</td>
                        <td>< 2.5</td>
                        <td>< 1.5 (Ideal < 1.0)</td>
                        <td>Measures cellular resistance to insulin.</td>
                    </tr>
                    <tr>
                        <td>HbA1c</td>
                        <td>< 5.7%</td>
                        <td>4.8% â€“ 5.2%</td>
                        <td>Long-term glycation of proteins.</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="inflammation">2. The Inflammation Trinity: hs-CRP, Homocysteine, and Ferritin</h2>
        <p>Inflammation is the "silent killer" that bridges the gap between the <span class="highlight">Exposome</span> (Module 2) and clinical disease. We track three primary markers to assess the systemic inflammatory load.</p>

        <h3>High-Sensitivity C-Reactive Protein (hs-CRP)</h3>
        <p>Unlike standard CRP, hs-CRP detects minute levels of systemic inflammation. A meta-analysis of 54 prospective studies (n=160,309) demonstrated that hs-CRP is as strong a predictor of cardiovascular disease as blood pressure or cholesterol.</p>
        <ul>
            <li><strong>Optimal:</strong> < 1.0 mg/L</li>
            <li><strong>Moderate Risk:</strong> 1.0 â€“ 3.0 mg/L</li>
            <li><strong>High Risk:</strong> > 3.0 mg/L (Persistent elevations suggest chronic hidden triggers).</li>
        </ul>

        <h3>Homocysteine: The Methylation & Vascular Marker</h3>
        <p>Homocysteine is a byproduct of the methionine cycle. High levels indicate either nutrient deficiencies (B12, Folate, B6) or genetic polymorphisms (MTHFR), causing direct damage to the vascular endothelium.
        <br><strong>Optimal Range:</strong> 5.0 â€“ 7.0 Âµmol/L (Conventional "normal" often goes up to 15.0).</p>

        <h3>Ferritin: The Inflammatory Chameleon</h3>
        <p>While often viewed as an iron storage marker, Ferritin is an <span class="highlight">acute-phase reactant</span>. In the presence of inflammation, the body sequesters iron in ferritin to "starve" potential pathogens. High ferritin (>150 ng/mL in women, >300 ng/mL in men) in the absence of iron overload (checked via Iron Saturation) is a potent indicator of liver inflammation or metabolic syndrome.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: The "Healthy" Executive</p>
                    <p style="color: rgba(255,255,255,0.8); margin:0; font-size:13px;">Metabolic Inflexibility in Plain Sight</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-info">
                        <h4>James, 46 | Symptoms: Fatigue, "Brain Fog," Abdominal Weight Gain</h4>
                        <p>Conventional Labs: Glucose 98 mg/dL (Normal), HbA1c 5.5% (Normal).</p>
                    </div>
                </div>
                <p><strong>Functional Analysis:</strong> James's Fasting Insulin was 18.2 ÂµIU/mL. His HOMA-IR was 4.4, indicating significant insulin resistance. His hs-CRP was 3.2 mg/L, suggesting systemic inflammation despite his "normal" glucose.</p>
                <p><strong>Intervention:</strong> Using the B.R.I.D.G.E. Method, we identified "Triggers" (high-fructose processed foods and circadian disruption). We shifted to a time-restricted feeding window and added alpha-lipoic acid.</p>
                <p><strong>Outcome:</strong> After 12 weeks, Fasting Insulin dropped to 6.4 ÂµIU/mL, and brain fog resolved entirely.</p>
            </div>
        </div>

        <h2 id="cardio">3. Cardiovascular Risk 2.0: ApoB and Lp(a)</h2>
        <p>The standard lipid panel (LDL, HDL, Triglycerides) is increasingly viewed as an incomplete diagnostic tool. To make <span class="highlight">Data-Driven Decisions</span>, we must look at the particles themselves.</p>

        <h3>Apolipoprotein B (ApoB)</h3>
        <p>Each atherogenic particle (LDL, VLDL, IDL) carries exactly one molecule of ApoB. Therefore, ApoB provides a direct count of the total number of "bad" particles. A 2021 study in <i>JAMA Cardiology</i> confirmed that ApoB is a superior predictor of risk compared to LDL-C, especially in patients with metabolic syndrome.</p>

        <h3>Lipoprotein(a) [Lp(a)]</h3>
        <p>Lp(a) is a highly inflammatory, genetically determined particle. High levels (>50 mg/dL or >125 nmol/L) significantly increase the risk of myocardial infarction and aortic stenosis, regardless of LDL levels. As an integrative practitioner, knowing a client's Lp(a) status is vital because it often requires more aggressive antioxidant and anti-inflammatory support.</p>

        <h2 id="uric">4. Uric Acid: The Metabolic Smoke Detector</h2>
        <p>Uric acid is often only checked when gout is suspected. However, in functional medicine, it serves as a <span class="highlight">metabolic smoke detector</span>. High uric acid (Optimal: 3.5 â€“ 5.5 mg/dL) is a byproduct of fructose metabolism and purine breakdown.</p>
        <p>When the liver processes fructose, it consumes ATP rapidly, leading to the production of uric acid. This uric acid then acts as a signaling molecule that triggers <span class="highlight">mitochondrial oxidative stress</span> and fat storage. If you see elevated uric acid, look for:
        <ul>
            <li>High fructose intake (HFCS, excessive fruit juice).</li>
            <li>Alcohol consumption (particularly beer).</li>
            <li>Hidden kidney stress or dehydration.</li>
        </ul></p>

        <h2 id="interplay">5. The Metabolic-Inflammatory Loop</h2>
        <p>It is impossible to separate metabolic health from inflammation. This relationship is mediated by <span class="highlight">Adipokines</span>â€”hormones secreted by fat tissue. In a state of insulin resistance, visceral adipose tissue becomes "inflamed," secreting IL-6 and TNF-alpha. These cytokines then travel to the liver, stimulating the production of CRP and further worsening insulin resistance at the muscle cell level.</p>

        <div class="principle-card">
            <div class="principle-title">The "D" in BRIDGE: The Triad of Dysfunction</div>
            <div class="principle-text">
                When analyzing labs, always look for the "Triad":
                <ul>
                    <li><strong>Triglyceride/HDL Ratio:</strong> > 2.0 suggests insulin resistance.</li>
                    <li><strong>hs-CRP:</strong> > 1.0 suggests the metabolic fire is burning.</li>
                    <li><strong>GGT (Gamma-Glutamyl Transferase):</strong> High-normal levels suggest liver oxidative stress.</li>
                </ul>
            </div>
        </div>

        <h2 id="clinical">6. Clinical Application Protocols</h2>
        <p>As an Integrative Medicine Practitioner, your role is to translate these numbers into a narrative for the client. We use the <span class="highlight">Functional Matrix</span> (Module 2) to map these biomarkers to the client's lifestyle.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Biomarker Pattern</th>
                        <th>Probable Root Cause</th>
                        <th>Intervention Focus</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td>High Insulin + High Uric Acid</td>
                        <td>Excess Fructose/Hyperinsulinemia</td>
                        <td>Low-Glycemic Diet, Berberine</td>
                    </tr>
                    <tr>
                        <td>High hs-CRP + High Ferritin</td>
                        <td>Systemic Inflammation/Infection</td>
                        <td>Omega-3s, Curcumin, Gut Health</td>
                    </tr>
                    <tr>
                        <td>High Homocysteine + Low B12</td>
                        <td>Methylation Deficit</td>
                        <td>Methylated B-Vitamins</td>
                    </tr>
                    <tr>
                        <td>High ApoB + High Triglycerides</td>
                        <td>Metabolic Inflexibility</td>
                        <td>Exercise, Carb Management</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your clinical reasoning with these scenarios.</p>

            <div class="question-item">
                <p class="question-text">1. A client presents with a "normal" Fasting Glucose of 92 mg/dL but a Fasting Insulin of 22 ÂµIU/mL. What is their HOMA-IR, and what does it indicate?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    Calculation: (92 Ã— 22) / 405 = 4.99. This indicates <strong>significant insulin resistance</strong>. Despite the normal glucose, the pancreas is overworking to maintain that level, a state that precedes Type 2 Diabetes by years.
                </div>
            </div>

            <div class="question-item">
                <p class="question-text">2. Why might a practitioner order an ApoB test instead of just relying on an LDL-C measurement?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    ApoB measures the <strong>total number</strong> of atherogenic particles. LDL-C only measures the mass of cholesterol inside them. A patient can have "low" LDL cholesterol but a "high" number of small, dense particles (high ApoB), which carries much higher vascular risk.
                </div>
            </div>
        </div>

        <div class="takeaways-box">
            <span class="box-label">Key Lesson Takeaways</span>
            <ul>
                <li><strong>Insulin is the Primary Driver:</strong> Fasting insulin and HOMA-IR reveal metabolic dysfunction long before glucose or HbA1c rise.</li>
                <li><strong>Inflammation is Systemic:</strong> hs-CRP, Homocysteine, and Ferritin provide a 360-degree view of the body's inflammatory burden.</li>
                <li><strong>Particle Count Matters:</strong> ApoB is the most accurate marker for atherogenic risk in modern cardiovascular science.</li>
                <li><strong>Uric Acid as a Signal:</strong> Use uric acid to detect fructose overconsumption and mitochondrial oxidative stress.</li>
                <li><strong>The B.R.I.D.G.E. Connection:</strong> Data-driven decisions allow us to Individualize (Module 3) care based on biological reality rather than symptoms alone.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>AraÃºjo, J., et al. (2019). "Prevalence of Optimal Metabolic Health in American Adults." <i>Metabolic Syndrome and Related Disorders.</i></li>
                <li>Ridker, P. M., et al. (2023). "Inflammation and cholesterol as predictors of cardiovascular events." <i>The Lancet.</i></li>
                <li>Sniderman, A. D., et al. (2021). "Apolipoprotein B vs Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol." <i>JAMA Cardiology.</i></li>
                <li>Johnson, R. J., et al. (2022). "The Fructose Survival Hypothesis: A New Theory of Obesity." <i>Philosophical Transactions of the Royal Society B.</i></li>
                <li>Perlmutter, D. (2022). "Drop Acid: The Surprising New Science of Uric Acid." <i>Little, Brown Spark.</i></li>
                <li>Kaptoge, S., et al. (2010). "C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis." <i>The Lancet.</i></li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="https://accredipro.com/wp-content/uploads/2023/05/AccrediPro-Logo-1.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy Â© 2024</p>
            <p class="copyright">Certified Integrative Medicine Practitioner Program | Module 4: Lesson 3</p>
        </footer>
    </div>
</body>

</html>